Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 1, 2004

View Archived Issues

Medarex to receive milestone payment from Amgen for antibody development

Gilead Sciences and Achillion collaborate on HCV compounds

Dyax grants use of antibody phage display libraries to Tanox

Amendment to terms of Vitex/Panacos merger

Progression of Lipid Sciences' Viral Immunotherapy program

Cardiome selects oral controlled-release formulation of RSD-1235

BioMarin plans phase III trial of Phenoptin for 2005

Medivir and Tibotec enter HCV license and research collaboration agreement

Avidia and Boehringer Ingelheim in development and manufacturing agreement

Bleeding associated with serotonin reuptake inhibition

HER2/ERBB3 pathway implicated in hormone refractory prostate cancer

A new prednisolone formulation shows promise in the treatment of UC

Clinical data on the efficacy of fenretinide in recurrent malignant gliomas

Cognitive benefits found with donepezil in MS patients with verbal memory impairment

Groundbreaking study to explore benefits of long-term pimecrolimus treatment

Good safety profile reported for C31G vaginal gel in healthy volunteers

New compounds for the treatment of psychiatric and mood disorders

Merck claims a series of CGRP receptor antagonists

GABA-A receptor modulators described by NeuroSearch

A series of protein tyrosine phosphatase inhibitors described in a patent

Dual acting compounds for the treatment of psychiatric disorders

Novel MAP kinase/TNF inhibitors in early development at Pfizer

Novartis researchers describe beta2-adrenergic agonists

Antibacterial oxazolidinones claimed by Pfizer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...